Now Is The Time To Build A Position In Standard BioTools Inc (NASDAQ:LAB)

Standard BioTools Inc (NASDAQ:LAB)’s traded shares stood at 2.1 million during the last session, with the company’s beta value hitting 1.53. At the close of trading, the stock’s price was $0.95, to imply a decrease of -8.22% or -$0.09 in intraday trading. The LAB share’s 52-week high remains $2.68, putting it -182.11% down since that peak but still an impressive 0.0% since price per share fell to its 52-week low of $0.95.

Analysts have given a consensus recommendation of Buy for Standard BioTools Inc (LAB), translating to a mean rating of 1.67. Of 3 analyst(s) looking at the stock, 0 analyst(s) give LAB a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 3 recommend it as a Buy.

Standard BioTools Inc (NASDAQ:LAB) trade information

After registering a -8.22% downside in the last session, Standard BioTools Inc (LAB) has traded red over the past five days. The 5-day price performance for the stock is -9.10%, and -23.02% over 30 days. With these gigs, the year-to-date price performance is -45.46%.

The extremes give us $3.25 and $3.25 for target low and target high price respectively. As such, LAB has been trading -242.11% off suggested target high and -242.11% from its likely low.

An assessment of the company’s 5-year growth patterns shows that annual earnings grew an estimated 11.61% for the past 5-year period. While 2025 is set for a 55.77% return in earnings, projections for the next 5 years are at 66.44% annually.

LAB Dividends

Standard BioTools Inc has its next earnings report out in June. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.

The next major institution holding the largest number of shares is VIKING GLOBAL INVESTORS LP with 58.65 million shares, or about 15.7524% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $103.81 million.